Pexelizumab Completed Phase 3 Trials for Acute Myocardial Infarction (AMI) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00091637Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)